PHAXIAM Therapeutics S.A. (PHXM) — Capital Reinvestment Ratio
PHAXIAM Therapeutics S.A. (PHXM) has a Capital Reinvestment Ratio of 0.08x as of December 2012, meaning it reinvests 0% of its operating cash flow (€621.40K) in capital expenditures (€48.40K). See PHAXIAM Therapeutics S.A. (PHXM) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
PHAXIAM Therapeutics S.A. Capital Reinvestment Ratio (2012–2012)
This chart tracks PHAXIAM Therapeutics S.A.'s Capital Reinvestment Ratio across 1 annual periods. Check PHAXIAM Therapeutics S.A. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for PHAXIAM Therapeutics S.A. (2012–2012)
Year-by-year Capital Reinvestment Ratio for PHAXIAM Therapeutics S.A. from 2012 to 2012. For live market cap and broader valuation context, see PHXM market cap.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2012 | 0.08x | €621.40K | €52.50K | — |